The efficacy of a modified mandibular advancement device for OSA treatment in a group of adult patients

Cranio. 2023 Aug 6:1-8. doi: 10.1080/08869634.2023.2242061. Online ahead of print.

Abstract

Objective: The Mandibular Advancement Device (MAD) is actually recommended for the treatment of Obstructive Sleep Apnea (OSA) with mild or moderate severity. The present study evaluated the effects of a fully customizable MAD-type device (It Makes You Sleep, IMYS), in patients with moderate-to-severe OSA.

Methods: Twenty-nine patients (15 men and 14 women; mean age 62, SD ±10 years) were retrospectively enrolled. Home Sleep Apnea Testing ;(HSAT) was performed for all patients at baseline (T0) and after three months (T1) of IMYS therapy. The analyzed respiratory parameters were: Apnea-Hypopnea Index (AHI), Oxygen Desaturation Index (ODI), Minimum Oxygen Saturation (minSO2) and Medium Oxygen Saturation (medSO2).

Results: From T0 to T1, a significant reduction of AHI and ODI was reported, as well as a significant increase of minSO2 and medSO2.

Conclusion: The IMYS device could be an effective MAD appliance for treating moderate-to-severe OSA.

Keywords: Obstructive sleep apnea; mandibular advancement; oral device.